Anti-inflammatory, antioxidant and immunomodulatory effects of curcumin in sensitized rat Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology Year: 2017
Nintedanib mediates effective modulation of relevant pro-fibrotic biomarkers ex vivo Source: International Congress 2019 – Pathogenesis and prognosis of interstitial lung disease of known origin Year: 2019
In vitro anti-inflammatory activity of the new glucocorticoid ciclesonide in human cellsSource: Eur Respir J 2001; 18: Suppl. 33, 95s Year: 2001
In vitro and in vivo anti-inflammatory activity of the novel PDE4 inhibitor roflumilastSource: Eur Respir J 2001; 18: Suppl. 33, 35s Year: 2001
Modeling in vitro, ex vivo or in vivo? Source: Research Seminar 2013 - Optimising models for human lung diseases and drug development Year: 2013
A combination of thyme and ivy exerts potent anti-inflammatory and mucus-normalizing activity in vivo and inhibits 5-LO and PDE4 Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014
Anti-tumour effects of coculture of dendritic cells with cytokine-induced killer cells against lung cancer in vitro and in vivo Source: Eur Respir J 2006; 28: Suppl. 50, 387s Year: 2006
Enhanced endothelial barrier protective and anti-inflammatory effects by synthetic iloprost-conjugated phospholipid. Source: International Congress 2018 – Triggers of acute lung injury: mechanical ventilation and oxygen levels Year: 2018
Mechanisms of vascular endothelial cell injury in response to intermittent and continuous hypoxia exposure and protective effects of anti-inflammatory and anti-oxidant agents Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases Year: 2019
The combination of budesonide and formoterol exerts more rapid and enhanced anti-inflammatory effects than either drug alone in rat lungs in vivo Source: Eur Respir J 2004; 24: Suppl. 48, 344s Year: 2004
Ovalbumin-induced asthma model in Brown Norway rats demonstrates potential anti-asthmatic effects of Neu-164, a novel antioxidant and anti-inflammatory compound Source: Annual Congress 2008 - Understanding allergic airway inflammation with the help of animal models Year: 2008
SDF-1 is an antifibrotic mediator in vivo Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020
Antifibrotic activities of pirfenidone in animal models Source: Eur Respir Rev 2011; 20: 85-97 Year: 2011
In vivo and in vitro effects of variants of Parj2 in asthmatic childrenSource: Eur Respir J 2005; 26: Suppl. 49, 658s Year: 2005
The effect of recombinant Il-8 on eosinophil migration in vitro and in vivo Source: Eur Respir J 2002; 20: Suppl. 38, 382s Year: 2002
ICS/LABA effects on antiviral innate immune response. An in vitro analysis. Source: International Congress 2019 – Novel targets and mechanisms in asthma Year: 2019
Anti-inflammatory role of myeloid-derived suppressor cells in asthma in vivo Source: International Congress 2017 – Therapeutic approaches in lung disease Year: 2017
Anti-inflammatory and anti-oxidative activity of YPL-001 in human bronchial epithelial cells Source: International Congress 2017 – Cigarette smoke and particulate matter: basic science and clinical aspects Year: 2017
Anti-inflammatory properties of synthetic and endogenous Rev-Erb-alpha agonists. Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms Year: 2020
Comparison of in-vitro anti-fibrotic effects of pirfenidone and nintedanib Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia Year: 2019